These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Reversible gynaecomastia associated with etritinate. Carmichael AJ; Paul CJ Br J Dermatol; 1989 Feb; 120(2):317. PubMed ID: 2923800 [No Abstract] [Full Text] [Related]
84. Omeprazole-induced galactorrhea in kidney transplant patients-a case report. Dorji C; Robin FA; Na-Bangchang K J Med Case Rep; 2022 Mar; 16(1):121. PubMed ID: 35339194 [TBL] [Abstract][Full Text] [Related]
85. Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review. Patel H; Arruarana V; Yao L; Cui X; Ray E Endocrine; 2020 Apr; 68(1):6-15. PubMed ID: 32067157 [TBL] [Abstract][Full Text] [Related]
86. Vitamin B Beltrame FL; de Santi F; Vendramini V; Cabral REL; Miraglia SM; Cerri PS; Sasso-Cerri E Front Endocrinol (Lausanne); 2019; 10():309. PubMed ID: 31354617 [TBL] [Abstract][Full Text] [Related]
87. Vitamin B Beltrame FL; Sasso-Cerri E Asian J Androl; 2017; 19(5):567-572. PubMed ID: 27568998 [TBL] [Abstract][Full Text] [Related]
88. Gynecomastia and drugs: a critical evaluation of the literature. Nuttall FQ; Warrier RS; Gannon MC Eur J Clin Pharmacol; 2015 May; 71(5):569-78. PubMed ID: 25827472 [TBL] [Abstract][Full Text] [Related]
89. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327 [TBL] [Abstract][Full Text] [Related]
90. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. García Rodríguez LA; Jick H BMJ; 1994 Feb; 308(6927):503-6. PubMed ID: 8136667 [TBL] [Abstract][Full Text] [Related]
92. Problems in the medical treatment of peptic ulcers. Wormsley KG J R Coll Physicians Lond; 1980 Jul; 14(3):169-72. PubMed ID: 7205728 [No Abstract] [Full Text] [Related]
98. Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A). Colle M; Ruedas E; Cazenave J; Auzerie J; Basilisco G; Camboni G; Manara L Eur J Clin Pharmacol; 1988; 35(5):529-34. PubMed ID: 2906873 [TBL] [Abstract][Full Text] [Related]
99. Adverse reactions and interactions with H2-receptor antagonists. Penston J; Wormsley KG Med Toxicol; 1986; 1(3):192-216. PubMed ID: 2878343 [TBL] [Abstract][Full Text] [Related]